ARDX Wutah bathi saben saham ing taun iki Ardelyx Corp

Simbol resmi perusahaan Ardelyx, Inc. (ARDX)

Current annual EPS growth confirms the expansion of Ardelyx, Inc. (ARDX) into nephrology through sales of Xphozah and Ibsrela. Innovative molecules for kidney and gastrointestinal health create sustainable patient loyalty, while a surge in prescriptions for the dialysis drug accelerates revenue. The indicator's trend shows that the value is holding at 26.60, reflecting the company's fundamental transition toward becoming an independent pharmaceutical leader.

Wutah bathi resik saben saham ing taun iki: Ardelyx, Inc. (ARDX) kanggo 04.07.2022 - 14.11.2026

Rincian analitis lan laporan data perusahaan Ardelyx (ARDX)

- kuotasi lan prakiraan analis:
Kurs saham Ardelyx Corp|ARDX - Bagan rega target
- data kapitalisasi pasar:
Kapitalisasi pasar Ardelyx|ARDX - Nilai Perusahaan
- informasi kapitalisasi buku:
Nilai Aset Bersih saben Saham Ardelyx|ARDX - Aset Bersih Perusahaan|Koefisien Nilai Pasar marang Nilai Buku ardelyx.com|ARDX - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Total Utang marang Modal Ardelyx, Inc.|ARDX - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Ardelyx|ARDX - Gunggung utang perusahaan|Rasio utang marang nilai buku Ardelyx|ARDX - Utang jangka dawa perusahaan|Utang jangka cendhak Ardelyx|Likuiditas cepet ardelyx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ARDX - Penghasilan resik|Bathi resik sing dikarepake Ardelyx, Inc.|ARDX - Koefisien rega marang bathi|Rasio rega marang bathi mangsa ngarep Ardelyx|ARDX - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Ardelyx|ARDX - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Ardelyx|ARDX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan ardelyx.com|ARDX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Ardelyx, Inc.
- statistik dodolan lan pendapatan perusahaan:
ARDX - Dodolan perusahaan|Dodolan mangsa ngarep perusahaan Ardelyx Pharma|ARDX - Multiplikator P/S|Multiplikator Forward P/S Ardelyx, Inc.
Pambiji fundamental:Ardelyx Pharma
Produk asil prodhuksi ardelyx.com

This indicator measures the year-over-year growth rate of earnings per share, determining the efficiency of business scaling and the justification for the market control premium. By analyzing the annual EPS range, an investor will see a direct correlation between the profitability of Ardelyx, Inc. (ARDX) and Medicare decisions as well as FDA approvals, which drive the influx of new patients into the company's unique pharma ecosystem.

Pesaing langsung

Wutah bathi saben saham ing taun iki TVTX|Wutah bathi saben saham ing taun lumaku ProKidney|Wutah bathi saben saham ing taun iki AKBA (Akebia Therapeutics)|Wutah bathi ing taun lumaku TVRD|DMAC - Kacepetan wutah bathi saben saham ing taun lumaku|unicycive.com - Wutah bathi resik saben saham ing taun iki|Rockwell Medical Inc. (RMTI) - Kacepetan wutah bathi saben saham ing taun lumaku|cadrenal.com - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku conduitpharma.com|CALT: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Renalytix PLC (RNLX)|Wutah bathi resik saben saham ing taun iki ZVSA